Clinivation WorldView is the medical device and diagnostic industry's most comprehensive, authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory Intelligence. Providing clear, step-by-step market clearance regulations, processes, and guidance for >99% of the world markets, only clinivation WorldView delivers tried-and-true intelligence from certified, practicing professionals with real-world experience.

Headquartered in Copenhagen, Denmark, Contura is a medical technology company that develops and markets soft tissue fillers. Contura's soft tissue fillers target both the medical and aesthetic markets. Two of the company's main products are AquamidŽ and Bulkamid®. Aquamid is a soft volume filler used to rejuvenate the face and enhance facial features. To date, plastic surgeons, dermatologists and cosmetic physicians have performed more than 300,000 Aquamid injections. Aquamid is available through a network of distributors covering 40 countries. Bulkamid is a urethral bulking agent used in the treatment of female urinary incontinence. Clinical studies have been performed in Europe and the FDA has granted Bulkamid an Investigational Device Exemption allowing it to be approved for clinical trials in the United States. Since 2007, ETHICON, a Johnson & Johnson company, has held exclusive worldwide distribution rights for Bulkamid, and the product is now available through ETHICON in Europe. The company's United States subsidiary office is in Jersey City, New Jersey.
For more information, please visit www.contura.com.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global® xi market clearance platform, clinivation WorldView® on-demand regulatory intelligence, and clinivation Clinical Suite® and clinivation Registry Suite® electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.